Lycopene from tomatoes partially alleviates the bleomycin-induced experimental pulmonary fibrosis in rats

Nutrition Research

Volumn 28, Issue 2, 2008, Pages 122-130

  Zhou, Changhua ^a   Han, Wei ^b   Zhang, Ping ^a   Cai, Meiying ^a   Wei, Dapeng ^a   Zhang, Chongjie ^a  

^a SICHUAN UNIVERSITY   (China)

^b CHENGDU MEDICAL COLLEGE   (China)

Author keywords

Histologic examination; Immunohistochemistry; Lycopene; Malonyldialdehyde; Nitric oxide; Pulmonary fibrosis; Rat; Superoxide dismutase; Tumor necrosis factor

Indexed keywords

BLEOMYCIN; LYCOPENE; MALONALDEHYDE; NITRIC OXIDE; OLIVE OIL; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; LUNG FIBROSIS; MACROPHAGE; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TOMATO;

ANIMALS; ANTIOXIDANTS; BLEOMYCIN; CAROTENOIDS; IMMUNOHISTOCHEMISTRY; LUNG; LYCOPERSICON ESCULENTUM; MALE; MALONDIALDEHYDE; NITRIC OXIDE; OXIDATIVE STRESS; PLANT OILS; PULMONARY FIBROSIS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

LYCOPERSICON ESCULENTUM; RATTUS;

EID: 38349161108     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2007.12.008     Document Type: Article

References (39)

1. Nguyen M.L., and Schwartz S.J. Lycopene: chemical and biological properties. Food Technol 53 (1999) 38-45
2. Gann P.H., Ma J., Giovannucci E., Willett W., and Sacks F.M. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 59 (1999) 1225-1230
3. Agarwal S., and Rao A.V. Tomato lycopene and its role in human health and chronic diseases. CMAJ 163 (2000) 739-744
4. Dimascio P., Kaiser S., and Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274 (1989) 532-538
5. Yanasaki H., Mesnil M., Omori Y., Mironov N., and Krutovskikh V. Intercellular communication and carcinogenesis. Mutat Res 333 (1995) 181-188
6. Bertram J.S., and Bortkiewicz H. Dietary carotenoids inhibit neoplastic transformation and modulate gene expression in mouse and human cells. Am J Clin Nutr 62 (1995) 1327S-1336S
7. Porrini M., and Riso P. Lymphocyte lycopene concentration and DNA protection from oxidative damage is increased in women after a short period of tomato consumption. J Nutr 130 (2000) 189-192
8. Kitade Y., Watanabe S., Masaki T., Nishioka M., and Nishino H. Inhibition of liver fibrosis in LEC rats by a carotenoid, lycopene, or a herbal medicine, Sho-saiko-to. Hepatol Res 22 (2002) 196-205
9. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161 (2000) 646-664
10. Clark J.G. BLM-induced pulmonary fibrosis in hamster. J Clin Invest 72 (1983) 2082-2088
11. Lazo J.S., Hoyt D.G., Sebti S.M., and Pitt B.R. Bleomycin: a pharmacologic tool in the study of the pathogenesis of interstitial pulmonary fibrosis. Pharmacol Ther 47 (1990) 347-358
12. Mutsaers S.E., McAnulty R.J., Laurent J., and Knight D.A. Evaluation of experimental models of idiopathic pulmonary fibrosis. Drug Discov Today Dis Model 1 (2004) 329-336
13. Periago M.J., Rincón F., Agüera M.D., and Ros G. Mixture approach for optimizing lycopene extraction from tomato and tomato products. J Agric Food Chem 52 (2004) 5796-5802
14. Ishida B.K., Ma J., and Chan B. A simple, rapid method for HPLC analysis of lycopene isomers. Phytochem Anal 12 (2001) 194-198
15. Thrall R.S., McCormick J.R., Jack R.M., McReynolds R.A., and Ward P.A. Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin. Am J Pathol 95 (1979) 117-130
16. Cohen L.A. A review of animal model studies of tomato carotenoids, lycopene, and cancer chemoprevention. Exp Biol Med (Maywood) 227 (2002) 864-868
17. Liu C., Lian F., Smith D.E., Russell R.M., and Wang X.D. Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets. Cancer Res 63 (2003) 3138-3144
18. Breinholt V., Lauridsen S.T., Daneshvar B., and Jakobsen J. Dose-response effects of lycopene on selected drug-metabolizing and antioxidant enzymes in the rat. Cancer Lett 154 (2000) 201-210
19. Garvey W. Modified elastic tissue-Masson trichrome stain. Stain Technol 59 (1984) 213-216
20. Szapiel S.V., Elson N.A., Fulmer J.D., Hunninghake G.W., and Crystal R.G. Bleomycin-induced interstitial pulmonary diseases in the nude, athymic mouse. Am Rev Respir Dis 120 (1979) 893-897
21. Failla M., Genovese T., Mazzon E., Gili E., Muià C., Sortino M., et al. Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury. Respir Res 7 (2006) 137
22. Barbarin V., Nihoul A., Misson P., Arras M., Delos M., Leclercq I., et al. The role of pro- and anti-inflammatory responses in silica-induced lung fibrosis. Respir Res 6 (2005) 112
23. Ludbrook J. Multiple comparison procedures updated. Clin Exp Pharmacol Physiol 25 (1998) 1032-1037
24. Fleiss J.L., Chilton N.W., and Wallenstein S. Ridit analysis in dental clinical studies. J Dent Res 58 (1979) 2080-2084
25. Bullimore D. RIDIT analysis for qualitative and subjective clinical data. Aliment Pharmacol Ther 2 (1988) 43-45
26. Thrall R.S., Barton R.W., DAmato D.A., and Sulavik S.B. Differential cellular analysis of bronchoalveolar lavage fluid obtained at various stages during the development of bleomycin-induced pulmonary fibrosis in the rat. Am Rev Respir Dis 126 (1982) 488-492
27. Sausville E.A., Peisach J., and Horwitz S.B. Effect of chelating agents and metal ions on the degradation of DNA by bleomycin. Biochemistry 17 (1978) 2740-2746
28. Adamson I.Y., and Bowden D.H. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 77 (1974) 185-197
29. Sies H., and Stahl W. Vitamins E and C, β-carotene, and other carotenoids as antioxidants. Am J Clin Nrtr 62 (1995) 1315S-1321S
30. Kinnula V.L., Fattman C.L., Tan R.J., and Oury T.D. Oxidative stress in pulmonary fibrosis. Am J Respir Crit Care Med 172 (2005) 417-422
31. Kim H.R., Park B.K., Oh Y.M., Lee Y.S., Lee D.S., Kim H.K., et al. Green tea extract inhibits paraquat-induced pulmonary fibrosis by suppression of oxidative stress and endothelin-1 expression. Lung 184 (2006) 287-295
32. Fantone J.C., and Phan S.H. Oxygen metabolite detoxifying enzyme levels in bleomycin-induced fibrotic lungs. Free Radic Biol Med 4 (1988) 399-402
33. Coker R.K., and Laurent G.J. Pulmonary fibrosis: cytokines in the balance. Eur Respir J 11 (1998) 1218-1221
34. Kelley J. Cytokines of the lung. Am Rev Respir Dis 141 (1990) 765-788
35. Piguet P.F., Collart M.A., Grau G.E., Kapanci Y., and Vassalli P. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 170 (1989) 655-663
36. Piguet P.F. Is "tumor necrosis factor" the major effector of pulmonary fibrosis?. Eur Cytokine Netw 1 (1990) 257-258
37. Piguet P.F., Collart M.A., Grau G.E., Sappino A.P., and Vassalli P. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature 344 (1990) 245-247
38. Ekekezie I.I., Thibeault D.W., Rezaeikhaligh M.H., Mabry S.M., Norberg M., Reddy G.K., et al. High-dose inhaled nitric oxide and hyperoxia increases lung collagen accumulation in piglets. Biol Neonate 78 (2000) 198-206
39. Piguet P.F., and Vesin C. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur Respir J 7 (1994) 515-518